Edward S. Lu

Edward S. Lu

Auto-generated profile, based on publicly available information

Edward S. Lu

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2023 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
GBGrace Baldwin
Grace Baldwin
FVFilippos Vingopoulos
Filippos Vingopoulos
Itika GargItika Garg
Itika Garg
JMJade Y. Moon
Jade Y. Moon
RZRebecca Zeng
Rebecca Zeng
JMJoan Miller
Joan Miller

13 April 2021 in Journal of Vitreoretinal Diseases
Verified
Journal Article
Closed access
PDF file
ELEdward S. Lu
Edward S. Lu
ABAugustine Bannerman
Augustine Bannerman
JMJoan Miller
Joan Miller

26 December 2025 in Journal of Vitreoretinal Diseases
Verified
Journal Article
Closed access
SSShivesh Shah
Shivesh Shah
ELEdward S. Lu
Edward S. Lu
IPIoanna Ploumi
Ioanna Ploumi
XDXinyi Ding
Xinyi Ding
YZYing Zhu
Ying Zhu
JMJoan Miller
Joan Miller
Purpose: To highlight the clinical utility of ultra-widefield swept-source optical coherence tomography angiography (SS-OCTA) in evaluating diabetic retinopathy (DR), particularly focusing on its ability to detect peripheral ischemia and neovascularization. Methods : Eyes of 5 participants with varying severity of DR were imaged with expanded-field 12 × 12-mm SS-OCTA scans and ultra-widefield SS-OCTA montages. Montages were created by stitching five 21 × 26-mm scans, offering up to a 200° field of view. Cases were assessed for areas of nonperfusion, intraretinal microvascular abnormalities, and neovascularization extending beyond the posterior pole. Results : Ultra-widefield SS-OCTA imaging demonstrated progressive mid-peripheral and peripheral nonperfusion, intraretinal microvascular abnormalities, and neovascularization in association with increasing DR severity. Peripheral nonperfusion and neovascular changes were detected beyond the scope of standard 12 × 12-mm scan areas. Conclusions : Ultra-widefield SS-OCTA is effective in noninvasively detecting peripheral retinal lesions such as ischemia and neovascularization. This technology offers potential to refine DR staging, improve risk stratification, and guide earlier clinical interventions.

11 May 2026 in Journal of Vitreoretinal Diseases
Verified
Journal Article
Closed access
ELEdward S. Lu
Edward S. Lu
LKLindsay Klofas Kozek
Lindsay Klofas Kozek
LMLuis Antonio Martinez-Velazquez
Luis Antonio Martinez-Velazquez
CSChristopher D. Stephen
Christopher D. Stephen
DEDean Eliott
Dean Eliott
Purpose: To describe atypical peripapillary retinal changes and neuroimaging findings in a patient with Gordon Holmes syndrome associated with compound heterozygous PNPLA6 variants, expanding the ophthalmic phenotype of this rare disorder. Methods: A single case was reviewed. Results: A 31-year-old woman with Gordon Holmes syndrome was referred for ophthalmic evaluation. Fundus autofluorescence imaging demonstrated atrophic peripapillary retinal pigment epithelial changes without central chorioretinal atrophy, distinguishing it from the phenotype typically seen in Boucher–Neuhäuser syndrome. Magnetic resonance imaging (MRI) of the brain revealed cerebellar atrophy and marked bilateral T2 hyperintensities in the basis pontis. Over 8 years of follow-up, visual acuity remained stable, with mild progression of pigment epithelial changes. Conclusions: Gordon Holmes syndrome may present with atypical peripapillary retinal changes and mild pigmentary retinopathy without clinically significant visual loss. These previously unrecognized retinal findings, along with atypical MRI features, broaden the ophthalmologic and neuroimaging spectrum of PNPLA6 -related disorders. Recognition of these manifestations may help ophthalmologists diagnose such rare neurodegenerative conditions.

2 July 2025 in International Ophthalmology Clinics
Verified
Journal Article
Closed access
ELEdward S. Lu
Edward S. Lu
FRFrancesco Md Romano
Francesco Md Romano
XDXinyi Ding
Xinyi Ding
JMJoan Miller
Joan Miller
Retinal imaging plays a critical role in the detection and management of proliferative diabetic retinopathy (PDR). Commonly used imaging modalities in the retina clinic include ultra-widefield fundus photography, ultra-widefield fluorescein angiography (FA), and optical coherence tomography (OCT). OCT angiography (OCTA) provides a noninvasive method to assess the retinal microvasculature and detect vascular alterations, including retinal neovascularization (NV). More recently, the emergence of expanded field swept-source OCTA (SS-OCTA) has offered faster en-face and cross-sectional imaging of the retina with a broader field of view. Prior reviews have highlighted the role of SS-OCTA in assessing associated lesions of PDR, including NV, microaneurysms, foveal avascular zone, intraretinal microvascular abnormalities, and capillary non-perfusion. In this review, we explore the clinical applications of expanded field SS-OCTA in characterizing NV morphology, comparing NV detection to FA, and offering potential imaging biomarkers associated with vision-threatening complications of PDR, including vitreous hemorrhage, neovascular glaucoma, and tractional retinal detachment.